147643-58-1

Upstream product

• 101711-90-4 (S)-4-benzyl-2-oxazolidinone lithium salt 
• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 
• 144-55-8 sodium hydrogencarbonate 
• 6831-55-6 2-(3,4-dichlorophenyl)acetyl chloride 
• 5807-30-7 3,4-dichlorophenyl acetic acid 

Downstream Products

• 147643-61-6 (S)-2-(3,4-dichlorophenyl)pent-4-enoic acid N-methyl amide 
• 156300-01-5 (S)-N-methyl-(2-(3,4-dichlorophenyl)pent-4-enyl)amine 
• 147643-57-0 (2S)-2-(3,4-dichlorophenyl)pent-4-enoic acid 
• 156300-02-6 (S)-2-(3,4-dichlorophenyl)pent-4-enoyl chloride 
• 250788-94-4 (S)-4-benzyl-3-(2-(3,4-dichlorophenyl)pent-4-enoyl)-2-oxazolidinone 

Relevant academic research and scientific papers

Carboxy substituted acylic carboxamide derivatives

The present invention relates to novel carboxy substituted acyclic carboxamide derivatives of formula (1)): STR1and stereoisomers and pharmaceutically acceptable salts thereof and their use as tachykinin receptor antagonists. Such antagonists are useful in the treatment of tachykinin-mediated diseases and conditions disclosed herein including: asthma, cough, and bronchitis.